Let's hope dosing starts in the next couple of weeks and not at the end of the Qrt. That would put us 6months behind from original guidance of Dec 2024. It also puts us 6months behind on readouts and puts us in precarious position if the piggy's aren't way in the money. First patient dosing is not going to increase the share price. Positive readouts will. But are we going to get anything significant from P1a or do we have to wait til P1b? genuine Q as this really puts pigs at risk. thanks
Ann: March 2025 Quarterly Activity Report and Appendix 4C, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
-0.040(3.38%) |
Mkt cap ! $198.9M | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.22 | $1.13 | $132.0K | 114.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2390 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 4805 | 1 |
View Market Depth
| Last trade - 15.57pm 04/07/2025 (20 minute delay) ? |
| RAC (ASX) Chart |